← Open Payments lookup

DIANA MIMS: Open Payments

NPI 1598469066 · GREENWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$966 in 44 payments from 11 companies in 2025. Trend: 2023 $294 · 2024 $353 · 2025 $966

Food & beverage: $753Education: $213
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$318
E.R. Squibb & Sons, L.L.C.11$179
Axsome Therapeutics, Inc.8$136
Neurocrine BioSciences, Inc.4$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$65
Supernus Pharmaceuticals, Inc.3$58
Lundbeck LLC3$50
ABBVIE INC.1$24
Alkermes, Inc.1$22
Vanda Pharmaceuticals Inc.1$19

Products named: COBENFY, Auvelity, AUSTEDO XR, INGREZZA, CAPLYTA, Qelbree, ABILIFY ASIMTUFII, VRAYLAR.

Industry payments across MS — which companies pay providers there.